SAMC
UTHR icon

Shinko Asset Management Company’s United Therapeutics UTHR Stock Holding History

Shinko Asset Management Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$16K Hold
135
– – ﹤0.01% 812
2016
Q2 		$14K Hold
135
– – ﹤0.01% 838
2016
Q1 		$15K Hold
135
– – ﹤0.01% 831
2015
Q4 		$21K Hold
135
– – ﹤0.01% 774
2015
Q3 		$18K Hold
135
– – ﹤0.01% 794
2015
Q2 		$23K Buy
+135
New +$24.3K ﹤0.01% 693

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Shinko Asset Management Company's UTHR Position: Q3 2016 in Review

Shinko Asset Management Company held its United Therapeutics (UTHR) position steady in Q3 2016 at 135 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #812.

Shinko Asset Management Company first reported a position in UTHR in Q2 2015 and has held it in 6 quarters since. The position peaked at $23K in Q2 2015. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Shinko Asset Management Company held 135 shares of United Therapeutics worth $16K as of Q3 2016.
  • Shinko Asset Management Company left its United Therapeutics share count unchanged in Q3 2016.
  • United Therapeutics made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #812 holding.
  • Shinko Asset Management Company first reported a position in United Therapeutics in Q2 2015 and has held it in 6 quarters since.
  • Shinko Asset Management Company's United Therapeutics position peaked at $23K in Q2 2015.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.